Express News | Exact Sciences Corp : Btig Raises Target Price to $82 From $70
Citi Maintains Exact Sciences(EXAS.US) With Buy Rating, Maintains Target Price $80
Citi analyst Patrick B Donnelly maintains $Exact Sciences(EXAS.US)$ with a buy rating, and maintains the target price at $80.According to TipRanks data, the analyst has a success rate of 48.9% and a
BTIG Maintains Exact Sciences(EXAS.US) With Buy Rating, Raises Target Price to $82
BTIG analyst Mark Massaro maintains $Exact Sciences(EXAS.US)$ with a buy rating, and adjusts the target price from $70 to $82.According to TipRanks data, the analyst has a success rate of 32.2% and
Buy Rating Affirmed for Exact Sciences on Robust CRC Test Results and Strategic Pipeline Advancements
Exact Sciences' New Test Positively Identifies More Than 88% of Cases of Colorectal Cancer, Company Says
ESMO 2024: Exact Sciences Unveils Results From Cancer Algorithm Trial